Estimating the programmatic cost of targeted mass drug administration for malaria in Myanmar

BMC Public Health

Table 3 Two-year programmatic costs of targeted MDA with different numbers of villages selected for targeted MDA

Cost of screening 272 villages using uPCR	Percentage of villages with targeted MDA	Number of villages	Cost of community engagement	Cost of mass treatment	Total cost	Cost per village^a	Cost per person reached^b
541,042	1%	13	56,735	111,551	709,328	579	1.9
541,042	2%	25	61,534	155,684	758,260	618	2.1
541,042	3%	37	66,332	199,816	807,190	658	2.2
541,042	4%	50	71,531	247,626	860,199	702	2.4
541,042	5%	62	76,330	291,759	909,131	742	2.5
541,042	6%	74	81,128	335,891	958,061	781	2.6
541,042	7%	86	85,927	380,024	1,006,993	821	2.8
541,042	8%	99	91,126	427,834	1,060,002	865	2.9
541,042	9%	111	95,924	471,966	1,108,932	905	3.0
541,042	10%	123	100,732	516,099	1,157,864	944	3.2

^aCost per village is estimated by dividing the total cost of targeted MDA by the total number of villages in the four townships (1226 villages). These targeted MDA costs will be shared among all villages in the region because targeted MDA is provided in addition to other malaria interventions, so the total cost is distributed among all villages in the region
^bCost per person reached is calculated by the total cost divided by the total population in that area (365000)
MDA Mass drug administration; uPCR Ultrasensitive polymerase chain reaction

ISSN: 1471-2458